Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Assessment of the Airway Smooth Muscle Relaxant Effect of Drotaverine.

Patai Z, Guttman A, Mikus EG.

Pharmacology. 2018;101(3-4):163-169. doi: 10.1159/000485921. Epub 2018 Jan 4.

PMID:
29301136
2.

Potential L-Type Voltage-Operated Calcium Channel Blocking Effect of Drotaverine on Functional Models.

Patai Z, Guttman A, Mikus EG.

J Pharmacol Exp Ther. 2016 Dec;359(3):442-451. Epub 2016 Oct 13.

PMID:
27738091
3.

Evaluation of SSR161421, a novel orally active adenosine A3 receptor antagonist on pharmacology models.

Mikus EG, Szeredi J, Boer K, Tímári G, Finet M, Aranyi P, Galzin AM.

Eur J Pharmacol. 2013 Jan 15;699(1-3):172-9. doi: 10.1016/j.ejphar.2012.11.049. Epub 2012 Dec 5.

PMID:
23219796
4.

Interaction of SSR161421, a novel specific adenosine A(3) receptor antagonist with adenosine A(3) receptor agonists both in vitro and in vivo.

Mikus EG, Boér K, Timári G, Urbán-Szabó K, Kapui Z, Szeredi J, Gerber K, Szabó T, Bátori S, Finet M, Arányi P, Galzin AM.

Eur J Pharmacol. 2013 Jan 15;699(1-3):62-6. doi: 10.1016/j.ejphar.2012.11.046. Epub 2012 Dec 5.

PMID:
23219789
5.

Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs.

Kapui Z, Schaeffer P, Mikus EG, Boronkay E, Gyürky J, Herbert JM, Pascal M.

Arzneimittelforschung. 1999 Aug;49(8):685-93.

PMID:
10483515
7.

Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]. 2nd communication: investigations on theophylline-like activities.

Mikus EG, Kapui Z, Korbonits D, Boér K, Boronkay E, Gyürky J, Révész J, Lacheretz F, Pascal M, Arányi P.

Arzneimittelforschung. 1997 Dec;47(12):1358-63.

PMID:
9450164

Supplemental Content

Loading ...
Support Center